Detalhe da pesquisa
1.
Mitochondrial complex III is essential for suppressive function of regulatory T cells.
Nature
; 565(7740): 495-499, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626970
2.
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Prostate
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641986
3.
Mitochondria in the regulation of innate and adaptive immunity.
Immunity
; 42(3): 406-17, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786173
4.
Mitochondrial metabolism is essential for invariant natural killer T cell development and function.
Proc Natl Acad Sci U S A
; 118(13)2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753493
5.
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
Oncologist
; 28(6): 465-473, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027449
6.
Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.
Immunity
; 38(2): 225-36, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23415911
7.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist
; 26(2): e270-e278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215787
8.
Physiological roles of mitochondrial reactive oxygen species.
Mol Cell
; 48(2): 158-67, 2012 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23102266
9.
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer.
Prostate
; 83(12): 1127-1132, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37244750
10.
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.
NPJ Genom Med
; 9(1): 7, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253539
11.
Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancer tumors.
Cancer Immunol Res
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701369
12.
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Nat Commun
; 15(1): 14, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167882
13.
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications.
Nat Rev Urol
; 20(5): 265-278, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543976
14.
MLH1 Loss in Primary Prostate Cancer.
JCO Precis Oncol
; 7: e2200611, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196219
15.
Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy.
Clin Genitourin Cancer
; 20(2): 97-101, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538582
16.
Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer.
JCO Oncol Pract
; 18(3): e403-e411, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34565170
17.
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.
J Clin Invest
; 132(23)2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194476
18.
Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Cancer Res
; 81(17): 4385-4393, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145040
19.
Targeting the spectrum of immune checkpoints in prostate cancer.
Expert Rev Clin Pharmacol
; 14(10): 1253-1266, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263692
20.
Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade.
Cold Spring Harb Mol Case Stud
; 7(4)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140335